口咽鳞状细胞癌患者预后影响因素分析

朱志高, 梁凯

朱志高, 梁凯. 口咽鳞状细胞癌患者预后影响因素分析[J]. 实用临床医药杂志, 2013, (11): 44-46,49. DOI: 10.7619/jcmp.201311014
引用本文: 朱志高, 梁凯. 口咽鳞状细胞癌患者预后影响因素分析[J]. 实用临床医药杂志, 2013, (11): 44-46,49. DOI: 10.7619/jcmp.201311014
ZHU Zhigao, LIANG Kai. Analysis of prognostic influential factors in patients with oropharyngeal squamous cell carcinoma[J]. Journal of Clinical Medicine in Practice, 2013, (11): 44-46,49. DOI: 10.7619/jcmp.201311014
Citation: ZHU Zhigao, LIANG Kai. Analysis of prognostic influential factors in patients with oropharyngeal squamous cell carcinoma[J]. Journal of Clinical Medicine in Practice, 2013, (11): 44-46,49. DOI: 10.7619/jcmp.201311014

口咽鳞状细胞癌患者预后影响因素分析

详细信息
  • 中图分类号: R766.4

Analysis of prognostic influential factors in patients with oropharyngeal squamous cell carcinoma

  • 摘要: 目的 探讨口咽鳞状细胞癌患者的预后现状和影响因素.方法 采用自制问卷收集2005年12月-2009年12月作者所在医院收治的69例口咽鳞状细胞癌患者的临床资料,根据口咽鳞状细胞癌患者的预后情况将其分为A组和B组.采用SPSS 19.0统计软件进行描述性统计和二分类Logistic回归分析口咽鳞状细胞癌预后现状和影响因素.结果 所有患者中,死亡患者42例,预后不良患者比例为60.87%;人乳头瘤病毒感染(OR=12.167)、淋巴结转移(OR=24.184)、情绪紧张(OR=8.576)、治疗并发症(OR=11.470)和基础疾病种数多(OR=12.198)是口咽鳞状细胞癌患者预后不良的危险因素;肿瘤组织分化程度高(OR=0.118)是口咽鳞状细胞癌患者预后良好的保护因素.结论 口咽鳞状细胞癌患者预后较差,预后结局受多方面因素影响,治疗中应采取针对性的预防干预措施来提高疗效,改善患者的预后.
  • Broglie M A, Soltermann A, Haile SR. Quality of life of oropharyngeal cancer patients with respect to treatment strategyand p16-positivity [J]. Laryngoscope, 2013(1):164.
    Loewenthal M, Vitez E, Laban S. New aspects of current therapeutic strategies in oropharyngeal carcinoma:high-lights of the 2012 ASCO meeting [J]. Hals Nasen Ohrenheikunde, 2012, (11):951.
    Adelstein D J, Ridge J A, Brizel D M. Transoral resection of pharyngeal cancer:summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia [J]. Head & Neck, 2012, (12):1681.
    Vikulova IuV. The state-of-the-art of the diagnosis of oral and oropharyngeal cancer [J]. Vestnik Rentgenologii I Radiologii, 2012(3):51.
    Perisanidis C, Sulzbacher I, Mittlb ck M. Survival of patients with pathologic T0N + oral and oropharyngeal cancer after neoadjuvant therapy and surgery:the minority report [J]. Oral Surgery Oral Medicine Oral Pathology Oral Radiology, 2013(3):293.
    Haughey B H, Sinha P. Prognostic factors and survival unique to surgically treated p16 + oropharyngeal eancer [J]. Laryngoscope, 2012, (Suppl 2):S13.
    许德斌, 陈文宽, 郭朱明. 口咽鳞状细胞癌患者治疗及预后因素分析 [J]. 中国耳鼻咽喉头颈外科, 2011(6):284.
    Wu Y, Posner M R, Schumaker L M. Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer:an analysis of the TAX 324 trial [J]. Cancer, 2012(7):1811.
    Kim T W, Choi S Y, Ko Y H. The Prognostic Role of p16 Expression in Tonsil Cancer Treated by Either Surgery or Radiation [J]. Clin Exp Otorhinolaryngol, 2012(4):207.
计量
  • 文章访问数:  165
  • HTML全文浏览量:  34
  • PDF下载量:  9
  • 被引次数: 0
出版历程
  • 发布日期:  2013-10-14

目录

    /

    返回文章
    返回